| |
| |
|
| Insider
Information: |
Barbo William D |
| Relationship: |
Corporate Executive VP... |
| City: |
Wilmington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,035 |
|
|
Indirect Shares
|
22,879 |
|
|
| Direct
Value |
$906,866 |
|
|
|
Indirect Value
|
$5,142,055 |
|
|
| Total
Shares |
26,914 |
|
|
| Total
Value |
$6,048,922 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 163.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Charles River Laboratories Inter... |
CRL |
Corporate Executive VP... |
2024-02-22 |
4,035 |
2024-02-22 |
22,879 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-03-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
754 |
3,015 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2023-08-10 |
4 |
S |
$217.24 |
$1,251,954 |
D/D |
(5,763) |
3,592 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-02-23 |
4 |
D |
$289.58 |
$91,218 |
D/D |
(315) |
3,769 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• – – |
2022-06-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
391 |
3,803 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• – – |
2022-12-02 |
4 |
S |
$218.28 |
$704,814 |
D/D |
(3,205) |
3,803 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,157 |
3,818 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-03-01 |
4 |
S |
$290.10 |
$1,013,312 |
D/D |
(3,493) |
3,818 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-02-22 |
4 |
D |
$293.61 |
$84,266 |
D/D |
(287) |
4,084 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-05-29 |
4 |
D |
$244.41 |
$49,371 |
D/D |
(202) |
4,194 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-06-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
252 |
4,371 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-08-06 |
4 |
S |
$400.83 |
$4,989,752 |
D/D |
(12,387) |
4,371 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,178 |
4,371 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-05-28 |
4 |
D |
$244.41 |
$27,374 |
D/D |
(112) |
4,396 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,493 |
4,508 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-05-29 |
4 |
D |
$337.99 |
$67,936 |
D/D |
(201) |
4,623 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,006 |
4,824 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-24 |
4 |
D |
$282.98 |
$91,120 |
D/D |
(322) |
4,975 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-23 |
4 |
D |
$283.59 |
$89,331 |
D/D |
(315) |
5,297 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-22 |
4 |
D |
$289.55 |
$83,101 |
D/D |
(287) |
5,612 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2020-03-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,151 |
5,899 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-02-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,154 |
5,899 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• – – |
2022-12-02 |
4 |
OE |
$109.34 |
$350,435 |
D/D |
3,205 |
7,008 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2021-03-01 |
4 |
OE |
$88.05 |
$307,559 |
D/D |
3,493 |
7,311 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2023-02-22 |
4 |
D |
$243.60 |
$69,913 |
D/D |
(287) |
8,476 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CCO |
• • – |
2023-01-27 |
4 |
D |
$244.29 |
$707,708 |
D/D |
(2,897) |
8,763 |
0 |
- |
|
96 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
